tirzepatide 3 month Micro-Dose Program (Three Months) Your First 3 Months on

Key Risks in Generic Supply: Learn about our quality standards: In pharmaceuticals, inconsistency is not just a riskit directly impacts patient safety and treatment outcomes

Primary and secondary outcome measures Change in HbA1c (primary endpoint) and BW (confirmatory secondary endpoint) from baseline to week 40

Best for patients with optimal weight loss goals

Treatment goals for orthostatic hypotension are reducing symptoms and improving quality of life

Although it is generally considered cardiometabolically beneficial, rare cardiac rhythm disturbances may occur

Thinking about switching from Tirzepatide to Semaglutide